Oct is @ANZUPtrials 111 #yourway mth. I will do 111 sit-ups/crunches daily. Aim to raise $111 per day. 111 represents the no. of #belowthebelt cancers diagnosed in Aus & NZ each day funds raised support #clinicaltrial research. My full story & donations 🙏 https://t.co/Kt2FHFEEYQ
Twice today already at ASCO I have heard presenters say “patients failed treatment”.
Can we please, please stop that?
Treatments fail patients, not the other way around…
@AlisonBirtle@tompowles1 Sometimes it’s better to know what not to do. That brings the whole world along, whereas a “+ve” trial is sometimes only a small step forward and not in practice until a long time after. Maybe time to retire the term “negative” and look instead at the effect on the whole field.
Welcome to 2026!
A little morning cloud on and south of the ranges, then a mostly sunny day throughout. Cool to mild in the south, warm in the north. SE winds. https://t.co/spelevacl3
Correlative work is possibly our most important tool in clinical trials. Congrats to @EdmondMKwan & #TheraP team for this insightful pub on ctDNA burden & PTEN loss predicting responses to 177Lu-PSMA & reminding us of his why - the patients behind the data. @ANZUPtrials#ANZUP25
@oncology_bg gives an engaging, hilarious, and deeply thought-provoking talk on common sense communication in @ANZUPtrials#ANZUP25 opening plenary session on “Connecting with big ideas.”
The #ANZUP25 ASM kicks off this Sunday!
Insightful sessions, expert speakers, and plenty of opportunity to connect with your GU peers.
Check your inbox to make sure you've downloaded the app to explore the program, plan your agenda, and stay updated. #listenreflectconnect
📣 The ANZUP 2024/25 Annual Report is now live!
Explore key research milestones, clinical innovations, and the impact we’re making together.
📖 Read the full report: https://t.co/wn2HzFO3ci
🚨 Late-breaker at #ASCO25!
Dr. Dickon Hayne presents LBA4504 – ANZUP 1301 trial
💥 Mitomycin + BCG vs BCG alone in high-risk NMIBC
➡️ Phase 3 results could change the game in bladder-sparing therapy!
#BladderCancer#UroOnc#ASCO2025
Watch Here -> https://t.co/ZoZ1zlWSl8
Well done! The @ANZUPTrials#BCGMM trial has been presented @ASCO25 showing BCG plus mitomycin a safe & effective alternative to BCG alone & the added benefit of requiring 40% fewer BCG doses. Congrats to Prof Dickon Hayne & team @Prof_IanD@TrialsCentre @MSD_Aus #OmegaPharm
Just had a great conversation with Dickon Hayne FRCS, MD, MBBS, of @RaineFoundation about updated data from the ANZUP study of mitomycin plus BCG as adjuvant intravesical therapy in high-risk NMIBC. Be sure to visit https://t.co/E5LOd0oQIM to learn more! @ANZUPtrials@ASCO#blcsm
Below the Belt Research Fund Grant applications are officially open! All necessary information and important details can be found on our website - https://t.co/ckZbPIcjKE